Home DailyMed 6cb023de-c758-41eb-9862-cd26fca43bb0 National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2012-07-24
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 02:00:18 Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022180-001 FERAHEME FERUMOXYTOL EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N022180-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 45 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 c2088c7a36db…2026-09-14 22:38:34 2026-08 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 84e616aacf4f…2026-08-18 06:07:40 2026-07 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS RLD, RS 2009-06-30 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS RLD, RS 2009-06-30 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS RLD, RS 2009-06-30 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS RLD, RS 2009-06-30 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS RLD, RS 2009-06-30 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS RLD, RS 2009-06-30 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N022180-001 FERAHEME EQ 510MG IRON/17ML (EQ 30MG IRON/ML) SOLUTION / INTRAVENOUS AB RLD, RS 2009-06-30 3bdfa0b2c4d7…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 2 · 54 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022180-001 6599498 2023-06-30 Drug substance, Drug product 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022180-001 6599498 2023-06-30 Drug substance, Drug product 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022180-001 6599498 2023-06-30 Drug substance, Drug product 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022180-001 7553479 2020-03-08 Drug substance, Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022180-001 7871597 2020-03-08 Drug substance, Drug product 2011-02-15 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022180-001 8501158 2020-03-08 U-1422 2013-08-06 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022180-001 8591864 2020-03-08 Drug product 2013-12-12 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022180-001 8926947 2020-03-08 Drug substance, Drug product 2015-01-08 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022180-001 6599498 2023-06-30 Drug substance, Drug product 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022180-001 6599498 2023-06-30 Drug substance, Drug product bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N022180-001 6599498 2023-06-30 Drug substance, Drug product 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022180-001 6599498 2023-06-30 Drug substance, Drug product 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N022180-001 6599498 2023-06-30 Drug substance, Drug product 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N022180-001 7553479 2020-03-08 Drug substance, Drug product 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N022180-001 7871597 2020-03-08 Drug substance, Drug product 2011-02-15 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N022180-001 8501158 2020-03-08 U-1422 2013-08-06 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N022180-001 8591864 2020-03-08 Drug product 2013-12-12 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N022180-001 8926947 2020-03-08 Drug substance, Drug product 2015-01-08 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N022180-001 6599498 2023-06-30 Drug substance, Drug product 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N022180-001 7553479 2020-03-08 Drug substance, Drug product c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N022180-001 7871597 2020-03-08 Drug substance, Drug product 2011-02-15 c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N022180-001 8501158 2020-03-08 U-1422 2013-08-06 c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N022180-001 8591864 2020-03-08 Drug product 2013-12-12 c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N022180-001 8926947 2020-03-08 Drug substance, Drug product 2015-01-08 c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N022180-001 6599498 2023-06-30 Drug substance, Drug product c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N022180-001 7553479 2020-03-08 Drug substance, Drug product 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N022180-001 7871597 2020-03-08 Drug substance, Drug product 2011-02-15 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N022180-001 8501158 2020-03-08 U-1422 2013-08-06 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N022180-001 8591864 2020-03-08 Drug product 2013-12-12 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N022180-001 8926947 2020-03-08 Drug substance, Drug product 2015-01-08 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N022180-001 6599498 2023-06-30 Drug substance, Drug product 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N022180-001 7553479 2020-03-08 Drug substance, Drug product b00525d2431f…2019-09-15 20:21 UTC 2019-09 N022180-001 7871597 2020-03-08 Drug substance, Drug product 2011-02-15 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N022180-001 8501158 2020-03-08 U-1422 2013-08-06 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N022180-001 8591864 2020-03-08 Drug product 2013-12-12 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N022180-001 8926947 2020-03-08 Drug substance, Drug product 2015-01-08 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N022180-001 6599498 2023-06-30 Drug substance, Drug product b00525d2431f…2019-07-19 19:46 UTC 2019-07 N022180-001 7553479 2020-03-08 Drug substance, Drug product ea99ee380514…2019-07-19 19:46 UTC 2019-07 N022180-001 7871597 2020-03-08 Drug substance, Drug product 2011-02-15 ea99ee380514…2019-07-19 19:46 UTC 2019-07 N022180-001 8501158 2020-03-08 U-1422 2013-08-06 ea99ee380514…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.